[1]
Uike, P., Hiwarkar, P., Malkar, V. and Aswalle, K. 2017. Profile of multi drug resistant (MDR) and rifampicin resistant TB patients treated under category IV of RNTCP. International Journal of Basic & Clinical Pharmacology. 6, 4 (Mar. 2017), 784–787. DOI:https://doi.org/10.18203/2319-2003.ijbcp20170992.